[306 Pages Report] The global neuronavigation systems market is forecasted to be appraised at US$ 4794.5 million by 2032, up from US$ 2120.0 million in 2022, advancing at a CAGR of 7.7% during the forecast period.
| Report Attribute | Details |
|---|---|
| Neuronavigation Systems Market Value (2022) | US$ 2120.0 Million |
| Neuronavigation Systems Market Anticipated Value (2032) | US$ 4794.5 Million |
| Neuronavigation Systems Projected Growth Rate (2022 to 2032) | 7.7% |
Neuronavigation refers to the set of computer-assisted technologies that are used by neurosurgeons for guiding or navigation within the confines of the skull or vertebral column during transactional magnetic stimulation or surgery.
The sales of neuronavigation systems are increasing as they have become a standard procedure for neurosurgery and associated specialties due to improved accuracy, efficiency and safety.
Moreover, neuronavigation systems are extensively being used in the operative management of brain tumors and are offering numerous clinical advantages to the surgeon.
In addition to that, neuronavigation systems increase the safety and accuracy of neurosurgery, helping the surgeons to visualize and navigate the confines of the vertebral column and skull of the patient during the surgery, which is likely to fuel the demand for neuronavigation systems.
Therefore, it is expected that the neuronavigation systems market is likely to have significant growth during the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The demand for neuronavigation systems market is likely to witness growth due to high demand and increasing need for systems that are accurate.
One of the key neuronavigation systems market growth drivers of the global neuronavigation systems is the growing incidences of neurological disorders such as cancer, brain tumors, and stroke.
Moreover, other functionalities like planning of incision and craniotomy and determination of small subcortical lesions by neuronavigation systems are also driving the demand for neuronavigation systems in the global market.
In addition to that, there is an introduction to new and innovative neuronavigation systems by market players, which is fueling the demand and the adoption of these systems in the global market.
Furthermore, it is estimated that with the use of neuronavigation systems, there will be improved outcomes and shortened hospital stays that will motivate the neuronavigation systems market to increase.
Neuronavigation systems are also used for brain biopsy. Deep tumors inside the brains are dangerous and difficult to approach by open surgery, which can be diagnosed by passing the biopsy probe through a small hole in the skull. This method is used to place electrodes in the brain to treat disorders such as Parkinson’s disease. Neuronavigation system localization can limit the size of the opening of the skill, and it is estimated that these factors are likely to drive the neuronavigation systems market size in the upcoming years.
It is anticipated that clinical complications related to neuronavigation systems, combined with the high cost of acquisition and maintenance of these systems, are some of the major factors that would restrain the growth of the global neuronavigation systems market.
In addition to that, brain shift is a type of deformation of the brain during surgery due to gravity, the volume of a resected tumor, the intraoperative position of the patient, and loss of cerebrospinal fluid, which gives no accuracy in the preoperative images for the real-time anatomy which hinder the growth of the neuronavigation system market globally.
Principal Consultant
At present, North America holds the highest share of the neuronavigation systems market. This region is accountable for 44.9% of the total market share of neuronavigation systems.
Due to the high prevalence of neurological disorders and demand for technologically advanced neurological systems, this region has a bolstering growth in its neuronavigation market size.
In addition to that, government funding in this region for the development of surgical navigation systems and the rising adoption of minimally invasive surgery is fueling the growth of the neuronavigation systems market in the North American regions.
Europe is currently accountable for 26.1% of the total market share of neuronavigation systems. It is anticipated that Europe is emerging in the neuronavigation systems market due to the adoption of advanced technologies and the rising incidence rate of disorders.
Furthermore, there is a development of the healthcare infrastructure in the European regions, which is driving the market size for neuronavigation systems.
The start-up ecosystem in the neuronavigation systems market is intense with frequent innovations being made. Start-ups in the neuronavigation systems market are focusing on improvising the tools for better implementation of surgical procedures.
Some of the new entrants in the market are – Happy Reliable Surgeries (HRS), which has emerged as the premier solution provider for neuro and ENT surgeries. HRS Navigation has many innovative tools which help surgeons to plan and execute surgery as per their plans. They are known to be a healthcare startup focused on providing innovative computer-assisted surgery solutions, HRS Navigation manufactures and markets high-tech surgical navigation systems.
The NeuroCare Group is a provider of neuromodulation and neurofeedback therapies for brain conditions. The company offers DC-EEG devices such as NEURO PRAX EEG, NEURO PRAX MR, and NEURO PRAX TMS/TES which are biofeedback systems. Also, offers transcranial electrical stimulation systems, transcranial magnetic stimulation, TMS neuronavigation, near-infrared spectroscopy, and others.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the key players in the global neuronavigation system market are ClaroNav, Stryker, Brainlab AG, Parsis, Northern Digital Inc., Heal Force, Medtronic, Synaptive Medical, Bramsys Indústria e Comércio Ltd.
The key market payers are continuously making efforts to collaborate and create innovative technologies for the benefit of the patient, with standard and minimally invasive procedures for neurosurgeries and associated specialties.
Some of the key developments in the neuronavigation systems market are:
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 7.7% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The growth outlook for the neuronavigation systems market is predicted to advance at a CAGR of 7.7% from 2022 to 2032.
The North American region is anticipated to lead the neuronavigation systems market during the forecast period.
The neuronavigation systems market is likely to hold a valuation of US$ 4794.5 million by 2032.
The healthcare industry sector is the key driver in the neuronavigation systems market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Neuronavigation Systems Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Neuronavigation Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032
5.3.1. Optical System
5.3.2. Electromagnetic System
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032
6. Global Neuronavigation Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032
6.3.1. Neurosurgery
6.3.2. ENT Surgery
6.3.3. Maxillofacial Surgery
6.3.4. Spinal Surgery
6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021
6.5. Absolute $ Opportunity Analysis By Application, 2022-2032
7. Global Neuronavigation Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Neuronavigation Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Product Type
8.2.3. By Application
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By Application
8.4. Key Takeaways
9. Latin America Neuronavigation Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product Type
9.2.3. By Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Application
9.4. Key Takeaways
10. Europe Neuronavigation Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Product Type
10.2.3. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Application
10.4. Key Takeaways
11. Asia Pacific Neuronavigation Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. Malaysia
11.2.1.5. Singapore
11.2.1.6. Australia
11.2.1.7. New Zealand
11.2.1.8. Rest of APAC
11.2.2. By Product Type
11.2.3. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Application
11.4. Key Takeaways
12. MEA Neuronavigation Systems Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of MEA
12.2.2. By Product Type
12.2.3. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Application
12.4. Key Takeaways
13. Key Countries Neuronavigation Systems Market Analysis
13.1. U.S.
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Product Type
13.1.2.2. By Application
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Product Type
13.2.2.2. By Application
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Product Type
13.3.2.2. By Application
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Product Type
13.4.2.2. By Application
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Product Type
13.5.2.2. By Application
13.6. U.K.
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Product Type
13.6.2.2. By Application
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Product Type
13.7.2.2. By Application
13.8. Spain
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Product Type
13.8.2.2. By Application
13.9. Italy
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Product Type
13.9.2.2. By Application
13.10. China
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Product Type
13.10.2.2. By Application
13.11. Japan
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Product Type
13.11.2.2. By Application
13.12. South Korea
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Product Type
13.12.2.2. By Application
13.13. Malaysia
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Product Type
13.13.2.2. By Application
13.14. Singapore
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Product Type
13.14.2.2. By Application
13.15. Australia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Product Type
13.15.2.2. By Application
13.16. New Zealand
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2021
13.16.2.1. By Product Type
13.16.2.2. By Application
13.17. GCC Countries
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2021
13.17.2.1. By Product Type
13.17.2.2. By Application
13.18. South Africa
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2021
13.18.2.1. By Product Type
13.18.2.2. By Application
13.19. Israel
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2021
13.19.2.1. By Product Type
13.19.2.2. By Application
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Product Type
14.3.3. By Application
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. ClaroNav
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Stryker
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. Brainlab AG
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Parsiss
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. Northern Digital Inc.
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. Heal Force
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. Medtronic
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. Synaptive Medical
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.9. Bramsys Indústria e Comércio Ltd
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Explore Healthcare Insights
View Reports
Neuronavigation Systems Market
